Neil Woodford’s Latest Buys And Sells: Mega-Million-Pound Calls On British American Tobacco plc, Rolls-Royce Holding PLC and Reynolds American, Inc

G A Chester examines Woodford’s buy and sell decisions on British American Tobacco plc (LON:BATS), Rolls-Royce Holding PLC (LON:RR) and Reynolds American, Inc. (NYSE:RAI).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

It’s always useful to see which shares the experts are buying and selling — and Neil Woodford is as expert as they come.

Through his Invesco Perpetual Income and High Income funds, Woodford looks after £25 billion of client money. His Income fund has generated a superb 210% return over the last 10 years, compared with an average 124% return by his peers.

The latest half-year report for the Income fund has just been published, and there’s an added piquancy, because the trades Woodford reports preceded an announcement on 15 October that he would be leaving Invesco next April.

Not kicking the habit

Woodford has a longstanding love affair with the tobacco sector. Indeed, backing this industry when it was out of favour has proven to be one of Woodford’s best calls.

During the 1990s, many commentators were confidently predicting litigation would be the death knell for tobacco companies. This year, the obituary writers are out again, mourning an impending death from plain packaging, education and declining sales volumes.

Meanwhile, Woodford has been increasing his net exposure to tobacco, while also rotating his favoured stocks within the sector.

Woodford reduced his holding in Reynolds American (NYSE: RAI.US) by 13%, netting proceeds of £77m. My calculations suggest he sold at between $49 and $50 a share — depending on the exchange rate at the time — when the owner of such iconic brands as Camel and Pall Mall was trading on an historic price-to-earnings (P/E) ratio of around 18.

Meanwhile Woodford spent £78m on increasing his shareholding in British American Tobacco (LSE: BATS) (NYSE: BTI.US) by 16%, and a further £59m on upping his stake in Imperial Tobacco by 13%.

My sums say Woodford paid 3,511p a pop for his British American Tobacco shares (at an historic P/E of less than 17) and 2,262p a share in the case of Imperial Tobacco (at an historic P/E of less than 12).

At the time of writing, you can buy British American Tobacco at 3,206p (9% less than Woodford paid), while Imperial Tobacco’s shares have risen 2% to 2,300p.

Taking some profit on high fliers

Woodford’s biggest FTSE 100 sell during the period was Rolls-Royce (LSE: RR) (NASDAQOTH: RYCEY.US), a company whose shares have more than quadrupled since their bear-market low of 2009.

The sale netted Woodford proceeds of £23m, but was a relatively small 5% ‘top-slice’ of his holding. According to my calculations, he sold at 1,246p a share, with the historic P/E standing at a heady 21, and the dividend yield at 1.6%. Rolls-Royce’s shares are currently trading 4% lower at 1,200p.

Woodford’s second largest British blue-chip sell — raising £20m — was Reckitt Benckiser. The consumer goods group, which owns brands such as Cillit Bang and Air Wick, saw its shares rise strongly through the first half of the year.

Again, Woodford’s sale represented a relatively small top-slice (4% of the holding). My sums say he sold at 4,837p a share, with the historic P/E at 18. Reckitt Benckiser’s shares are currently trading a tad lower at 4,816p.

Buying 40% of a company

There wasn’t too much change in Woodford’s net exposure to healthcare — another of his favourite industries — and AstraZeneca and GlaxoSmithKline remain the fund’s top two holdings.

However, Woodford did buy a whopping 40% of a smaller company in the sector! In an interesting move, he participated in a £30m initial public offering (IPO) for AIM-market debutante NetScientific. The company, which is chaired by pharma industry veteran Sir Richard Sykes, a former chairman of GlaxoSmithKline, commercialises late-stage research from US and UK universities.

The companies in NetScientific’s portfolio include, WANDA, which has designed a wireless digital health system for the remote management of chronic diseases, and Vortex BioSciences, which is developing a novel technology for blood-based cancer diagnosis and monitoring.

Woodford bought NetScientific shares at 160p in the IPO; today, they’re trading at 135p.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

> G A Chester does not own any shares mentioned in this article. The Motley Fool has recommended shares in GlaxoSmithKline.

More on Investing Articles

artificial intelligence investing algorithms
Growth Shares

The next industrial revolution has begun. Here are 3 growth stocks at its heart

Edward Sheldon believes these three growth stocks will do well as the AI industry grows and the world becomes more…

Read more »

Investing Articles

Given the current economic climate, is there value to be found in UK penny stocks?

Our writer evaluates the prospects of two promising penny stocks on the London Stock Exchange. They each have a compelling…

Read more »

Investing Articles

With yields at 9%+, I expect even more from these FTSE 100 dividend stocks

I'd thought FTSE 100 yields might be declining by now, as the stock market starts to gain. Can these big…

Read more »

A young black man makes the symbol of a peace sign with two fingers
Investing Articles

2 risky shares for investors to consider buying

It’s important to consider what could go wrong when working out which shares to buy. But sometimes the potential rewards…

Read more »

Investing Articles

After crashing 63% can the Burberry share price ever recover?

Harvey Jones thought he was clever when he bought Burberry shares after a recent profit warning, but instead he's taking…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

With interest rates at 5%, are Stocks and Shares ISAs still worth it?

Savings accounts are paying chunky interest right now. However, a Stocks and Shares ISA still offers higher returns in the…

Read more »

Growth Shares

Here are the latest share price forecasts for Rolls-Royce

The Rolls-Royce share price has risen about 700% over the last two years. Here’s where City analysts expect it to…

Read more »

Diverse group of friends cheering sport at bar together
Investing Articles

Up 21% in a month! Is this world-class FTSE 250 share finally fulfilling its explosive potential?

Harvey Jones reckons this breathtaking FTSE 250 share could transform his portfolio by turning into a brilliant multi-bagger. But it…

Read more »